Oncopeptides AB (publ) (STO:ONCO)

Oncopeptides AB Employees

Oncopeptides AB had 75 employees as of December 31, 2025. The number of employees decreased by 5 or -6.25% compared to the previous year.

• Employees: 75
• Change: -5
• Growth: -6.25%
• Revenue / Employee: 1.11M SEK
• Profits / Employee: -2.95M SEK
• Market Cap: 699.66M

Employees History

Date	Employees	Change (1Y)	Growth (1Y)
Dec 31, 2025	75	-5	-6.25%
Sep 30, 2025	75	-4	-5.06%
Jun 30, 2025	75	8	11.94%
Mar 31, 2025	75	13	20.97%
Dec 31, 2024	80	23	40.35%
Sep 30, 2024	79	15	23.05%
Jun 30, 2024	67	4	6.35%
Mar 31, 2024	62	3	5.08%
Dec 31, 2023	57	16	39.02%
Sep 30, 2023	64	24	60.50%
Jun 30, 2023	63	19	43.18%
Mar 31, 2023	59	-17	-22.37%
Dec 31, 2022	41	-121	-74.69%
Sep 30, 2022	40	-281	-87.54%
Jun 30, 2022	44	-269	-85.94%
Mar 31, 2022	76	-218	-74.15%
Dec 31, 2021	162	-118	-42.14%
Sep 30, 2021	321	89	38.36%
Jun 30, 2021	313	159	103.25%
Mar 31, 2021	294	173	142.98%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Employee data is provided by S&P Global Market Intelligence and updates every three months after the filing of each quarterly report.

Update frequency:

Quarterly

Last checked:

Jun 10, 2026

Data Sources Report a data error